Combination of triazine derivatives and PPAR&agr;agonists

Details for Australian Patent Application No. 2006334735 (hide)

Owner Merck Patent GmbH

Inventors Moinet, Gerard; Mesangeau, Didier; Cravo, Daniel

Agent Davies Collison Cave

Pub. Number AU-A-2006334735

PCT Pub. Number WO2007/079918

Priority 06/00345 13.01.06 FR

Filing date 18 December 2006

Wipo publication date 19 July 2007

International Classifications

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

Event Publications

4 September 2008 PCT application entered the National Phase

  PCT publication WO2007/079918 Priority application(s): WO2007/079918

16 July 2009 Assignment before Grant

  Merck Patent GmbH The application has been assigned to POXEL SAS 2007

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006334742-Double-roll machine for comminuting a bed of material

2006334734-Combination of triazine derivatives and insulin sensitisers